Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
-$0.17 today
- Market cap
- $271.79M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
Volume 0.05M
Average 0.04M
TTRX Long-term Debt
Borrowings due after more than one year.
Turn Therapeutics Inc.NASDAQ: TTRX
Long-term Debt · Q1 FY2026 · quarter ended Mar 2026
Long-term debt of $5.94M in Q1 FY2026
Q1 FY2026 long-term debt was $5.94M.
Context
- Long-term debt amounted to 31.8% of total assets at the end of Q1 FY2026.
- Long-term debt increased in 0 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
Long-term Debt vs competitors
How TTRX compares with its peers on the latest reported figures
- TTRX's Mar 2026 long-term debt of $5.94M is the 4th highest of the 9 companies compared; the peer median is $0.
- Long-term debt amounts to 31.8% of total assets for TTRX, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $153.99M | +368.8% | +138.0% | 82.6% | |
IRDOpus Genetics, Inc. | Mar 2026 | $25.93M | — | — | 38.8% |
| Mar 2026 | $20.38M | — | — | 7.5% | |
TTRXTurn Therapeutics Inc. | Mar 2026 | $5.94M | — | — | 31.8% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Apr 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TTRX) | $0 | +368.8% | +138.0% | 0.0% | |
Competitors are the stored peer set for TTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Turn Therapeutics Inc.
NASDAQ:TTRX
Intrinsic Alpha fair value
Locked
Current Price
$8.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.